Terminated NA INTERVENTIONAL 2-arm NCT05279534

Efficacy and Safety of L. Plantarum and P. Acidilactici in Children With Upper Respiratory Tract Infections

Efficacy and Safety of Lactobacillus Plantarum and Pediococcus Acidilactici as Twice-daily Co-adjuvant Therapy of Upper Respiratory Tract Infections in Children 6 Months to 5 Years Old

Sponsor: AB Biotics, SA

Conditions Pharyngitis Tonsillitis Upper Respiratory Tract Infections

Interventions Placebo Probiotic

Updated 5 times since 2022 Last updated: Oct 16, 2023 Started: Mar 8, 2022 Primary completion: Jun 2, 2023 Completion: Jun 2, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor decision

Other terminated trials from AB Biotics, SA

More terminations from AB Biotics, SA

Listed as NCT05279534, this NA trial focuses on Pharyngitis and Tonsillitis and remains terminated or withdrawn. Sponsored by AB Biotics, SA, it has been updated 5 times since 2022, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Nov 2023 — Jul 2024 [monthly]

Terminated NA

Status: Active Not Recruiting → Terminated
May 2023 — Nov 2023 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Apr 2022 — May 2023 [monthly]

Recruiting NA

First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AB Biotics, SA
Hospital General Dr. Manuel Gea González
Innovacion y Desarrollo de Estrategias en Salud

Data source: AB Biotics, SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico